Exploring the Anti-Glioma Mechanisms of Oridonin: Network Pharmacology and Experimental Insights into EMT Pathways
Oridonin may provide a novel therapeutic approach for glioma by targeting EMT-related pathways, offering a foundation for further clinical investigation.
Authors
- Zhezhong Zhang
- Yibo He (ORCID: https://orcid.org/0000-0002-8043-4727)
- Changjiang Wu (ORCID: https://orcid.org/0000-0003-2547-7895)
- Yi-Ran Fei
- Shiliang Chen (ORCID: https://orcid.org/0000-0001-7079-3307)
- Shiyuan Tong (ORCID: https://orcid.org/0000-0002-7899-5728)
- Cong Wang (ORCID: https://orcid.org/0000-0002-6063-9311)
- Xiaoli Jin (ORCID: https://orcid.org/0000-0002-5039-1850)
Institutions
- Zhejiang Chinese Medical University (CN)
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Suzhou Kowloon Hospital (CN)
- State Key Laboratory of Medical Neurobiology
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-10-09
- DOI
- https://doi.org/10.2174/0109298673390934250923111917
- Primary Topic
- Bioactive Natural Diterpenoids Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00